Key Etomidate Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mylan N.V. (Viatris)
- Gland Pharma Ltd.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- B. Braun Melsungen AG
- Teva Pharmaceutical Industries
- Troikaa Pharmaceuticals Ltd.
- Sagent Pharmaceuticals
- Samyang Biopharmaceuticals
- Baxter International Inc.
- Hameln Pharma GmbH
- Nichi-Iko Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Grifols S.A.
- Aspen Pharmacare
- Pharmaniaga Berhad
- Cipla Ltd.
- Accord Healthcare
The etomidate market is gearing up for 2024, with Pfizer leading the pack, closely followed by Mylan/Viatris and Gland Pharma. This really showcases the strong presence of both U.S. and Indian companies in this field. To keep their edge, these companies are focusing on ready-to-administer formulations, refining active pharmaceutical ingredients (APIs), and actively engaging in government tenders. Ultimately, factors like competitive pricing, regulatory approvals, and being included in formularies are crucial differentiators across various markets.
Top Global Manufacturers in the Etomidate Market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2025, the industry size of etomidate is estimated at USD 328.5 million.
Etomidate Market size was valued at USD 312.2 million in 2024 and is projected to reach USD 591.5 million by the end of 2037, rising at a CAGR of 5% during the forecast period, 2025 to 2037.
The North America etomidate market is projected to account for a leading share of 34% by the end of 2037.
The major players in the market are Pfizer Inc., Mylan N.V. (Viatris), Gland Pharma Ltd., Hikma Pharmaceuticals PLC, Aurobindo Pharma, Jiangsu Nhwa Pharmaceutical Co., Ltd., B. Braun Melsungen AG, Teva Pharmaceutical Industries, Troikaa Pharmaceuticals Ltd., Sagent Pharmaceuticals, Samyang Biopharmaceuticals, Baxter International Inc., Hameln Pharma GmbH, Nichi-Iko Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Grifols S.A., Aspen Pharmacare, Pharmaniaga Berhad, Cipla Ltd., Accord Healthcare.
